Main > > >GYNECOLOGY.

---

Endometriosis. Pain. TREAT.: Elagolix
Tablets.
Gonadotropin-Releasing Hormone (GnRH) Antagonist.
USA Approval Date: 2018. 07.24.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2018. 09.28.




Hysteroscopy System.
USA Clearance Date: 2018. 09.13.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2020. 02.25.




InFertility. TREAT.: Brand Follitropin Delta. Human rFSH.
CH Approval Date: 2017. 11.27.
EU Approval Date: 2016. 12.13.
(*) Company & TradeMark Available on
Request.
UpDate: 2017. 11.28.




Menorrhagia. Treat.: Water Vapor Abla-
tion System 2nd Generation (G).
USA Approval Date: 2020. 03.24.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2020. 03.30.




Nausea & Vomiting of Pregnancy ("NVP")
(Morning Sickness).
TREAT.: Doxylamine Succinate+Piridoxine.
HCl ER Tablets.
USA Approval Year: 2016.
USA Launch Date : 2018. 04.02.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.




picoAMH ELISA>Aid in Determination of
Menopausal Status
USA De Novo FDA Clearance: 2018. 10.25.
(*) Company; Patent APP.; TradeMark &
Web-Site Available on Request.
UpDate: 2018. 11.01.




PostPartum Haemorrhage (PPH). Prevention
CarbeTocin. (OxyTocin Analog)
EU Approval Date: 2015. 04.07.
(*) Company; Patent; TradeMark & Web-
Site Available on Request.
UpDate: 2018. 08.04.




Pregnancy Prevention.
Drospirenone+Ethinyl Estradiol Tablets.
Generic.
USA Launch Date: 2018. 04.25.
(*) Company: Mylan NV.
UpDate: 2018. 04.26.




Pregnancy Prevention. Levonorgestrel+Ethinyl Estradiol
(0.1 mg/20 mcg) Tablets & Ferrous Bisglycinate Tablets 36.5 mg.
USA Approval Date: 2018. 01.17.
(*) Company : Avion Pharmaceuticals LLC.
TradeMark: Balcoltra.
UpDate: 2018. 01.18.




Pregnancy Prevention. Medroxyprogesterone Acetate
Injectable Suspension, USP. (Generics)
USA Approval Date: 2017. 11.29.
(*) Company: Amphastar Pharmaceuticals.
UpDate: 2017. 12.01.




Pregnancy Prevention. Medroxyprogesterone Acetate
Injectable Suspension, USP. (Generics)
USA Launch Date: 2018. 10.18.
(*) Company: Mylan
UpDate: 2018. 10.19.




Pregnancy Test. Flushable, Biodegradable Pregnancy Test.
USA 510(k) Clearance for OTC Use: 2017. 12.05.
(*) Company; Patent & Web-Site Availa-
ble on Request.
UpDate: 2017. 12.06.




PreTerm Birth. Prevention: Hydroxyprogesterone Caproate Inj. Brand.
USA Drug Approval Date : 2011. 02.
USA Drug+AutoInjector Approval Date: 2018. 02.14.
(*) Companies; Patent; TradeMarks & Web-Site Available on Request
UpDate: 2018. 03.19.




PreTerm Birth. Prevention: Hydroxyprogesterone Caproate Inj. Gene-
ric.
USA Approval Date: 2019. 01.02.
(*) Company: Slayback Pharma LLC.
UpDate: 2019. 01.03.




PreTerm Birth. Spontaneous PreTerm
Birth. Risk Point-Of Care Test.
Reducing Unnecessary Hospital Admissions and Safeguarding Babies.
A non-invasive strip test that provides results in five minutes or less.
The novel test detects placental alpha microglobulin-1 (PAMG-1) in patients presenting with signs and symptoms of preterm labor.
USA Approval Date: 2018. 04.20.
(*) Company : QIAGEN N.V.
TradeMark: PartoSure
UpDate: 2018. 04.21.




Uterine Fibroids. Treat.: Elagolix, Es-
tradiol, & Norethindrone Acetate Capsu-les; Elagolix Capsules.
USA Approval Date: 2020. 05.29.
(*) Company; TradeMark & Web-Site Avai-
lable on Request.
UpDate: 2021. 03.06.




Uterine Fibroids. Treat.: Embolic Beads.
RadioOpaque.
Enabling Real-Time Visible, Lasting
Confirmation of Bead Location during
& Post-Embolisation ..
Visible Imaging>Computed Tomography
>Cone-Beam Computed
Tomography
>Fluoroscopy
USA Approval Date: 2015. 12.14.
USA Launch Date: 2016. 04.01.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2018. 10.23.




Uterine Fibroids. Treat.: Embolic Beads.
CA Approval Year: 2005.
EU Approval Year: 2003.
(*) Company : BTG Intl.
TradeMark: Bead Block.
UpDate: 2018. 10.23.




Uterine Fibroids. Treat.: Embolization.
500 Embolization Biodegradable Micro-
Spheres Detectable by UltraSound.
CA Approval Date : 2018. 11.21.
USA Approval Date: ?
(*) Company; Patent; TradeMark & Web-
Site Available on Request.
UpDate: 2018. 11.25.




Uterine Fibroids. Treat.: Embolization.
Pressure-Directed Arterial Embolization.
Balloon Occlusion Microcatheters. (U>E)
EU Clearance Date: 2018. 08.31.
USA Clearance Date: 2018. 06.28.
(*) Company; Patent; TradeMark & Web-
Site Available on Request.
UpDate: 2018. 10.25.




Uterine Fibroids. Treat.: High Inten-
sity Focused UltraSound (HIFU) (U>M)
EU Approval Date: 2017. 03.24.
(*) Company; Patents & Web-Site Avai-
lable on Request.
UpDate: 2018. 08.31.




Uterine Fibroids. Treat.: RadioFrequen-
cy (RF) Ablation, Ultrasound (US)
Visualization & Guidance Mapping System.
(U>A)
USA FDA Clearance Date: 2018. 10.02.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2018. 10.03.




Uterine Fibroids. Treat.: Sonography-Guided Transcervical Fibroid Ablation System. (U>G)
Incision-Free.
EU Approval Date : 2014. 06.24.
USA Approval Date: 2018. 08.22.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2018. 08.29.




Uterine Fibroids. Treat.: Ulipristal Acetate Tablets. (F)
Risk of Liver Injury.
CA Approval Date: 2016. 11.21.
EU Approval Date: 2012.
(*) Companies; Patent; TradeMarks &
Web-Site Available on Request.
UpDate: 2018. 08.30.




Vulvar & Vaginal Atrophy. (VVA) TREAT.: Estradiol Vaginal Cream USP, 0.01%. Generic. (I)
USA Approval Date: 2018. 01.24.
USA Launch Date : 2018. 04.06.
(*) Companies Available on Request.
UpDate: 2018. 04.07.




Vulvar & Vaginal Atrophy. (VVA) TREAT.: Estradiol Vaginal Cream USP, 0.01%. Generic. (U)
USA Approval & Launch Date: 2017. 12.29.
(*) Company Available on Request.
UpDate: 2017. 12.30.




Vulvar & Vaginal Atrophy. (VVA) TREAT.: Estradiol Vaginal Inserts. (U)
USA Approval Date: 2018. 05.30.
USA Launch Date : 2018. 09.13.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2018. 09.14.


>GYNECOLOGY.'s products
This section has no products